
MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. Key highlights include: (CAD) Q4 2025 % Changevs…
MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) BioSyent Inc. (BioSyent, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, … [+6751 chars]




